BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 35992872)

  • 1. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
    Chen H; Li W; Wan C; Zhang J
    Front Oncol; 2022; 12():942943. PubMed ID: 35992872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
    Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
    J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
    Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between diffusion-weighted imaging and breast cancer biomarkers.
    Martincich L; Deantoni V; Bertotto I; Redana S; Kubatzki F; Sarotto I; Rossi V; Liotti M; Ponzone R; Aglietta M; Regge D; Montemurro F
    Eur Radiol; 2012 Jul; 22(7):1519-28. PubMed ID: 22411304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic contrast-enhanced and diffusion-weighted MRI of invasive breast cancer for the prediction of sentinel lymph node status.
    Choi EJ; Youk JH; Choi H; Song JS
    J Magn Reson Imaging; 2020 Feb; 51(2):615-626. PubMed ID: 31313393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Added value of histogram analysis of apparent diffusion coefficient maps for differentiating triple-negative breast cancer from other subtypes of breast cancer on standard MRI.
    Liu HL; Zong M; Wei H; Wang C; Lou JJ; Wang SQ; Zou QG; Jiang YN
    Cancer Manag Res; 2019; 11():8239-8247. PubMed ID: 31564982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis.
    Surov A; Chang YW; Li L; Martincich L; Partridge SC; Kim JY; Wienke A
    BMC Cancer; 2019 Nov; 19(1):1043. PubMed ID: 31690273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic contrast-enhanced magnetic resonance imaging features and apparent diffusion coefficient value of HER2-positive/HR-negative breast carcinoma.
    Chen P; Zhao S; Guo W; Shao G
    Quant Imaging Med Surg; 2023 Aug; 13(8):4816-4825. PubMed ID: 37581065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Added value of mean and entropy of apparent diffusion coefficient values for evaluating histologic phenotypes of invasive ductal breast cancer with MR imaging.
    Suo S; Zhang D; Cheng F; Cao M; Hua J; Lu J; Xu J
    Eur Radiol; 2019 Mar; 29(3):1425-1434. PubMed ID: 30116958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
    Nie T; Feng M; Yang K; Guo X; Yuan Z; Zhang Z; Yan G
    Sci Rep; 2023 Dec; 13(1):21451. PubMed ID: 38052920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
    Tezcan S; Ozturk FU; Uslu N; Akcay EY
    Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of Prognostic Factors and Genotypes in Patients With Breast Cancer Using Multiple Mathematical Models of MR Diffusion Imaging.
    Wang W; Zhang X; Zhu L; Chen Y; Dou W; Zhao F; Zhou Z; Sun Z
    Front Oncol; 2022; 12():825264. PubMed ID: 35174093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Dynamic Contrast-Enhanced MRI and Non-Mono-Exponential Model-Based Diffusion-Weighted Imaging for the Prediction of Prognostic Biomarkers and Molecular Subtypes of Breast Cancer Based on Radiomics.
    Zhang L; Zhou XX; Liu L; Liu AY; Zhao WJ; Zhang HX; Zhu YM; Kuai ZX
    J Magn Reson Imaging; 2023 Nov; 58(5):1590-1602. PubMed ID: 36661350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.